StockMirror — Stock Screener

PRIVISCL Q2 FY27 Results & Earnings Analysis

Sentiment: Good (Confidence: high)

Earnings Summary

Privi Speciality Chemicals reported its strongest ever quarterly performance with record revenue of INR773.16 crores (up 13.9% YoY) and EBITDA of INR212.49 crores (up 16.66% YoY), PAT of INR117.03 crores (up 24.61% YoY). Management declared first interim dividend of INR5/share. Phase 1 capacity expansion completed (48,000 to 54,000 MTPA), with volume ramp-up expected in Q4 FY27. Company maintains 20% growth guidance and expects to maintain EBITDA margins. Phase 2 and 3 expansions on track for ~INR1,900 crores revenue by 2030. Balance sheet strong with ROCE 24.30%, net debt/EBITDA 1.07x, working capital cycle below 100 days. Key risks include geopolitical uncertainty and input cost volatility.

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management emphasized 20% revenue growth and maintaining EBITDA margins, with focus on profitable growth and cash generation.

About Privi Speciality Chemicals Limited

Privi Speciality Chemicals Limited (PRIVISCL) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More